Vicarious Surgical Inc (NYSE:RBOT) CTO Sammy Khalifa Sells 754 Shares

Vicarious Surgical Inc (NYSE:RBOT) CTO Sammy Khalifa sold 754 shares of the stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $14.53, for a total transaction of $10,955.62. Following the completion of the sale, the chief technology officer now owns 36,927 shares in the company, valued at $536,549.31. This represents a 2.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Sammy Khalifa also recently made the following trade(s):

• On Monday, December 23rd, Sammy Khalifa sold 112 shares of Vicarious Surgical stock. The stock was sold at an average price of $12.19, for a total transaction of $1,365.28.
• On Tuesday, December 3rd, Sammy Khalifa sold 239 shares of Vicarious Surgical stock. The stock was sold at an average price of $13.46, for a total transaction of $3,216.94.

Vicarious Surgical Trading Down 2.7 %

Shares of Vicarious Surgical stock traded down $0.40 on Friday, hitting $14.22. 40,941 shares of the company traded hands, compared to its average volume of 52,425. The firm’s 50-day simple moving average is $13.64 and its 200 day simple moving average is $10.02. The company has a market cap of $84.04 million, a P/E ratio of -1.38 and a beta of 1.32. Vicarious Surgical Inc has a 12-month low of $4.27 and a 12-month high of $19.00.

Analyst Upgrades and Downgrades

Separately, Piper Sandler lowered their price objective on shares of Vicarious Surgical from $12.00 to $10.50 and set a “neutral” rating on the stock in a research report on Wednesday, November 13th.

Institutional Trading of Vicarious Surgical

Several institutional investors and hedge funds have recently made changes to their positions in RBOT. Renaissance Technologies LLC raised its position in shares of Vicarious Surgical by 11.6% during the 4th quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock valued at $152,000 after buying an additional 1,200 shares in the last quarter. DnB Asset Management AS raised its position in Vicarious Surgical by 21.1% in the 4th quarter. DnB Asset Management AS now owns 21,213 shares of the company’s stock worth $279,000 after purchasing an additional 3,692 shares during the period. Finally, Geode Capital Management LLC raised its position in Vicarious Surgical by 8.2% in the 4th quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock worth $405,000 after purchasing an additional 2,336 shares during the period. Hedge funds and other institutional investors own 47.27% of the company’s stock.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.